Navigation path

Themes
Agriculture & food
Energy
Environment
ERA-NET
Health & life sciences
  Allergy & asthma
  Biotechnology
  Communicable diseases
  Drugs & drug processes
  Genetic engineering
  Genomics
  Health & ageing
  Health & poverty
  Health & special needs
  Health systems & management
  Major diseases
  Medical research
  Molecular biology
  Neuroscience
  Public health
  Rare & orphan diseases
  Other
Human resources & mobility
Industrial research
Information society
Innovation
International cooperation
Nanotechnology
Pure sciences
Research infrastructures
Research policy
Science & business
Science in society
Security
SMEs
Social sciences and humanities
Space
Special Collections
Transport

Countries
Countries
  Argentina
  Australia
  Austria
  Belgium
  Benin
  Brazil
  Bulgaria
  Canada
  Chile
  China
  Colombia
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Egypt
  Estonia
  Finland
  France
  Georgia
  Germany
  Ghana
  Greece
  Hungary
  Iceland
  India
  Indonesia
  Ireland
  Israel
  Italy
  Japan
  Kazakhstan
  Kenya
  Korea
  Latvia
  Lithuania
  Luxembourg
  Malaysia
  Malta
  Mexico
  Montenegro
  Morocco
  Namibia
  Netherlands
  Nigeria
  Norway
  Peru
  Poland
  Portugal
  Romania
  Russia
  Serbia
  Slovakia
  Slovenia
  South Africa
  Spain
  Sri Lanka
  Swaziland
  Sweden
  Switzerland
  Taiwan
  Tanzania
  Thailand
  Tunisia
  Turkey
  Ukraine
  United Kingdom
  United States


This page was published on 10/01/2007
Published: 10/01/2007

   Success Stories

Last Update: 10-01-2007  
Related category(ies):
Health & life sciences  |  International cooperation

 

Add to PDF "basket"

Transatlantic cooperation creating world's largest genome bank

The European Commission, US National Institutes of Health and Genome Canada are co-funding a global collaborative research programme aiming at creating mutant mouse lines in every single gene present in the mouse genome. The goal is to better understand the ways a single gene influences the health and well-being of mice by deleting, or “knocking out”, individual genes. Through the study of the mouse genome, researchers expect to gain invaluable insight into disease processes in humans, as mice and humans share 99 percent of their genetic code. In addition to the current initiative, the EU has invested over €135 million since 2002 in mouse functional genomics, easily putting Europe at the forefront of genomic research.

The mouse genome holds a wealth of information regarding human diseases, though unlocking it won't come cheap. © Matt+
The mouse genome holds a wealth of information regarding human diseases, though unlocking it won't come cheap.
Researchers plan to make each mutant line of mouse created through the international project publicly available to all scientists. By conducting the experiment on such a large scale, experts will generate the modified mice in a standardised and cost-effective manner.

A recent Nature article on the initiative notes that similar such experiments are not widely reported due to the fact that they are often carried out in the private sector. It goes on the say that out of the 4 000 mutant K.O. lines that have been published, only 1 000 are open to public use.

“There isn't a common mechanism in place to enforce deposition of K.O. mouse lines into public repositories,” Wolfgang Wurst, coordinator of the European Conditional Knockout Mouse Mutagenesis (EUCOMM) initiative, told Nature. So, experts decided to “generate a comprehensive and public resource of mouse mutant lines,” Nature reports.

This international collaborative project is one of the largest research endeavours ever conceived, second only to the Human Genome Project, to produce mutations in all the mouse genes. The project will target around 20 000 individual genes.

This world-wide mouse mutagenesis collaborative effort networks three major initiatives: The EUCOMM project financed by the European Commission with €13 million, the NorCOMM project which received €4.4 million from the Canadian government and the Knockout Mouse Project (KOMP) project financed by the US-NIH with €39.2 million.

In addition, the European Commission also supports (€12 million) a new project: European Mouse Disease Clinic (EUMODIC) to be launched in February 2007. EUMODIC aims at the detailed molecular analysis of a large number (>600) of these newly created mouse K.O. mutants lines.

The mouse experiments will give researchers the opportunity to mimic human diseases, and ultimately speed up drug development to fight those diseases.

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also

EUCOMM
EUMODIC
Nature
DG Research press release





  Top   Research Information Center